Victrex (LON:VCT) Hits New 1-Year High – Here’s Why

Victrex plc (LON:VCT)’s stock price reached a new 52-week high during trading on Wednesday . The stock traded as high as GBX 823 and last traded at GBX 821.75, with a volume of 215338 shares changing hands. The stock had previously closed at GBX 811.

Analyst Ratings Changes

Several research firms have issued reports on VCT. Jefferies Financial Group restated a “hold” rating and issued a GBX 595 price target on shares of Victrex in a research report on Tuesday, July 7th. UBS Group reaffirmed a “sell” rating and set a GBX 575 price objective on shares of Victrex in a research report on Monday, May 11th. Canaccord Genuity Group cut shares of Victrex to a “buy” rating and set a GBX 725 target price for the company. in a research note on Friday, May 15th. Finally, Berenberg Bank lifted their target price on Victrex from GBX 600 to GBX 680 and gave the stock a “hold” rating in a research report on Wednesday, July 8th. Two analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of GBX 663.33.

Victrex Trading Up 0.7%

The firm has a market capitalization of £711.81 million, a P/E ratio of -36.47, a PEG ratio of 1.92 and a beta of 0.77. The company has a quick ratio of 1.99, a current ratio of 2.35 and a debt-to-equity ratio of 21.30. The business has a 50-day moving average price of GBX 662 and a 200-day moving average price of GBX 646.75.

Victrex (LON:VCT) last issued its earnings results on Monday, May 11th. The company reported GBX 17.20 EPS for the quarter. The business had revenue of £147.10 million during the quarter. Victrex had a negative return on equity of 4.95% and a negative net margin of 6.70%. Analysts anticipate that Victrex plc will post 73.1078905 earnings per share for the current year.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.